Clark C R, Sansom R T, Lin C M, Norris G N
J Med Chem. 1985 Sep;28(9):1259-62. doi: 10.1021/jm00147a024.
A series of 4-aminobenzanilides derived from ring-alkylated anilines were prepared and evaluated for anticonvulsant activity. These benzanilides were prepared in the course of studies designed to determine the relationship between the benzamide structure and anticonvulsant effects. The compounds were tested in mice against seizures induced by electroshock and metrazole (pentylenetetrazole) and in the rotorod assay for neurologic deficit. All of the 4-aminobenzanilides showed activity at doses of 300 mg/kg against maximal electroshock seizures (MES). The 4-aminobenzanilide derived from 2,6-dimethylaniline (8) was the most potent anti-MES compound with an ED50 of 2.60 mg/kg and a protective index of 5.77 (PI = TD50/ED50). The activity profile for 8 compares quite favorably with that for phenobarbital and phenytoin in the same assays.
制备了一系列由环烷基化苯胺衍生的4-氨基苯甲酰苯胺,并对其抗惊厥活性进行了评估。这些苯甲酰苯胺是在旨在确定苯甲酰胺结构与抗惊厥作用之间关系的研究过程中制备的。在小鼠中测试了这些化合物对电休克和戊四氮(五甲烯四氮唑)诱导的癫痫发作的作用,并在转棒试验中测试了其对神经功能缺损的影响。所有4-氨基苯甲酰苯胺在300mg/kg剂量下对最大电休克癫痫发作(MES)均显示出活性。由2,6-二甲基苯胺衍生的4-氨基苯甲酰苯胺(8)是最有效的抗MES化合物,其半数有效剂量(ED50)为2.60mg/kg,保护指数为5.77(PI = TD50/ED50)。在相同试验中,化合物8的活性谱与苯巴比妥和苯妥英的活性谱相比相当有利。